Methods for diagnosing and treating diseases and conditions of the digestive system and cancer

Details for Australian Patent Application No. 2002354947 (hide)

Owner The General Hospital Corporation

Inventors Fishman, Mark C.; Mayer, Alan N.

Agent Pizzeys

Pub. Number AU-B-2002354947

PCT Number PCT/US02/22904

PCT Pub. Number WO2003/007800

Priority 60/306,319 17.07.01 US

Filing date 17 July 2002

Wipo publication date 3 March 2003

Acceptance publication date 17 April 2008

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/46 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/306,319 17.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002354947

17 April 2008 Application Accepted

  Published as AU-B-2002354947

14 August 2008 Standard Patent Sealed

10 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002354948-METHOD FOR PRODUCTION OF MULTIMODAL POLYOLEFINS OF TUNABLE COMPOSITION, MOLECULAR WEIGHT, AND POLYDISPERSITY

2002354946-METHODS AND COMPOSITIONS FOR MODULATING T-TYPE CALCIUM CHANNELS